CervoMed Inc. beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.87 | $-0.64 | +26.4% | Beat |
| Q12026 FY2026 | $-0.90 | $-0.86 | +4.4% | Beat |
| Q42025 FY2025 | $-0.79 | $-0.88 | -11.4% | Miss |
Back to CRVO overview · CRVO holders · CRVO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.